|
Microorganism*
|
Infection with new microorganism within 30 days of first date of ertapenem use (%)
|
Carbapenem resistance (%)
|
|---|
|
Pseudomonas aeruginosa
|
50 (5.5)
|
25 (2.8)
|
|
Stenotrophomonas maltophila
|
21 (2.3)
|
21 (2.3)**
|
|
Acinetobacter baumannii
|
27 (3.0)
|
20 (2.2)
|
|
Enterobacteriaceae (such as Klebsiella spp., E. coli, Proteus spp.) with ESBL production
|
41 (4.5)
|
8 (0.9)
|
- *More than one microorganism was isolated in some cases within 30 days from initiation of ertapenem therapy.
- **Carbapenem sensitivity testing was not performed. However, Stenotrophomonas maltophila is intrinsically resistant to carbapenems.
